As of 2023, hospital discharges for Crohn's Disease and Ulcerative Colitis in France stood at 19.3 units per hundred thousand persons. Forecasts from 2024 to 2028 suggest a consistent annual decline. The year-on-year reductions are approximately 2.7% in 2024, 2.7% in 2025, 2.7% in 2026, 2.3% in 2027, and 2.3% in 2028. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is a decline of approximately 2.6%, indicating a steady reduction in hospital discharge rates for these conditions.

Future trends to watch for include:

Impact of newer medical treatments and management strategies on reducing the incidence and severity of Crohn's Disease and Ulcerative Colitis.
Potential changes in healthcare policies or hospital practices that could further influence discharge rates.
Public health initiatives aimed at increasing awareness and early intervention, potentially altering hospitalization trends.